Alison Lawton

Alison Lawton

Director/Board Member at DIANTHUS THERAPEUTICS, INC.

Net worth: 71 817 $ as of 30/03/2024

62 year
Health Technology
Commercial Services
Consumer Services

Profile

Alison Francis Lawton is currently the Director at AgBiome INC, Independent Director at X4 Pharmaceuticals, Inc., Director at SwanBio Therapeutics, Inc., Independent Director at Dianthus Therapeutics, Inc., Independent Member-Supervisory Board at ProQR Therapeutics NV, and President at Cadena Bio, Inc. Previously, she served as the Chairman & President at Regulatory Affairs Professionals Society, Independent Director at Cubist Pharmaceuticals LLC, Director at CoLucid Pharmaceuticals, Inc., Independent Director at Spyre Therapeutics, Inc., Director at Follica, Inc., Director at Massachusetts Medical Device Industry Council, Independent Director at Verastem, Inc., Director at Kaleido Biosciences, Inc., Director at Magenta Therapeutics, Inc., Senior Vice President at Genzyme Corp., Chief Operating Officer at Aura Biosciences, Inc., Principal at Parke-Davis & Co. Ltd., General Manager at Genzyme Biosurgery Corp., General Manager-Biosurgery at Sanofi, Inc., Chief Operating Officer at OvaScience, Inc., Head-Genzyme Biosurgery at Sanofi-Aventis, Inc., Chief Operating Officer at X4 Pharmaceuticals, Inc., and Senior Vice President & General Manager at BIOSURGERY S.R.L.
She obtained her undergraduate degree from King's College London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/06/2023 51,667 ( 0.03% ) 71 817 $ 30/03/2024
30/12/2023 0 ( -.--% ) - $ 30/03/2024
10/09/2023 0 ( -.--% ) - $ 30/03/2024

Alison Lawton active positions

CompaniesPositionStart
PROQR THERAPEUTICS N.V. Director/Board Member 16/09/2014
X4 PHARMACEUTICALS, INC. Director/Board Member 04/10/2020
DIANTHUS THERAPEUTICS, INC. Director/Board Member 10/09/2023
President -
Director/Board Member 03/05/2021
Director/Board Member 18/01/2021
All active positions of Alison Lawton

Former positions of Alison Lawton

CompaniesPositionEnd
SPYRE THERAPEUTICS, INC. Director/Board Member 31/01/2024
KALEIDO BIOSCIENCES, INC. Chief Executive Officer 15/06/2020
VERASTEM, INC. Director/Board Member 18/05/2020
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Alison Lawton's experience

Training of Alison Lawton

King's College London Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alison Lawton's experience

Connections

100 +

1st degree connections

24

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies7
AURA BIOSCIENCES, INC.

Health Technology

SPYRE THERAPEUTICS, INC.

Health Technology

VERASTEM, INC.

Health Technology

PROQR THERAPEUTICS N.V.

Health Technology

KALEIDO BIOSCIENCES, INC.

Health Technology

X4 PHARMACEUTICALS, INC.

Health Technology

DIANTHUS THERAPEUTICS, INC.

Health Technology

Private companies16

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

BIOSURGERY S.R.L.

See company connections